Factors influencing the discontinuation of biologic therapies in patients with ulcerative colitis

• Main Authors: Arisa Fukuyama (Author), Akio Nakashima (Author), Motoyasu Miyazaki (Author), Masakatsu Fujiki (Author), Hideki Kakimoto (Author), Takashi Hisabe (Author), Osamu Imakyure (Author)
• Format: Book
• Published: BMC, 2024-10-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background The therapeutic landscape for ulcerative colitis (UC) has recently broadened to include anti-TNFα, anti-integrin, and anti-IL-12/23p40 antibody agents. These biological agents are tailored to individual patient profiles. However, some patients cease biological treatment. This stu...